Here, transplantation of MSCs into FoxC1-transfected vascular niches resulted in greater improvement in the survival rate and cardiac remodeling of MI rats via decreasing myocardial inflammatory and fibrosis and increasing angiogenesis in comparison with MSC therapy alone. This evidence concerns the gene FOXC1 and myocardial infarction.